Shanghai-based life sciences counsel Katherine Wang and associate Fan Yang co-authored an article that examines the impact of recent transfer rule changes and new Good Manufacturing Practice requirements announced earlier this year by the China Food and Drug Administration. These developments present significant opportunities and considerations. The article, entitled “China Offers New Possibilities for Drug License Transfers,” published in the May/June 2013 issue of the Food and Drug Law Institute’s Update magazine.
Click here to view the full article. Reprinted with permission of FDLI.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.